WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,140.00
-300.00 (-3.55%)
At close: Mar 31, 2026
Market Cap107.47B +27.6%
Revenue (ttm)106.44B +3.6%
Net Income4.97B +3.8%
EPS376.00 +3.9%
Shares Out13.20M
PE Ratio21.65
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume74,082
Average Volume155,390
Open8,440.00
Previous Close8,440.00
Day's Range8,130.00 - 8,450.00
52-Week Range5,720.00 - 11,950.00
Beta0.79
RSI48.68
Earnings Daten/a

About KOSDAQ:330350

WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea. It offers circulatory agents, endocrine cost medications, osteoporosis treatment products, antithrombotic medicines, central nervous system agents, digestive tract medications, respiratory/skin preparations, musculoskeletal medications, antibiotics, antifungal and antiviral drugs, genitourinary tract medications, psychotropic agents, and other products. The company was previously known as Withers Medipharm Co. , Ltd. and changed its name... [Read more]

Industry Pharmaceutical Preparations
Founded 2004
Employees 121
Stock Exchange KOSDAQ
Ticker Symbol 330350
Full Company Profile

Financial Performance

In 2025, KOSDAQ:330350's revenue was 106.44 billion, an increase of 3.62% compared to the previous year's 102.72 billion. Earnings were 4.97 billion, an increase of 3.81%.

Financial Statements